Date: 2016-09-01
Type of information: Nomination
Compound:
Company: Diamyd Medical (Sweden)
Therapeutic area: Autoimmune diseases - Metabolic diseases - Regenerative diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On September 1, 2016, Diamyd Medical announced that Martina Widman, M.Sc. in Mechanical Engineering from the Royal Institute of Technology in Stockholm and employed in Diamyd Medical since 2008, as of September 1 succeeds Erika Hillborg as Director of Clinical Development. Martina Widman will be a member of Diamyd Medical's management team.
Financial terms:
Latest news:
